Human astrocytes are increasingly appreciated as important contributors to brain function in health and disease, but techniques to study them are limited. In this issue of Neuron, Sloan and colleagues (2017) describe a new 3D culture model that generates mature human astrocytes, opening the door to future studies of their function.
What makes the human brain special? It has been proposed that it isn't just the properties of neurons that are unique to the human brain but differences in the number and properties of non-neuronal glial cells that allow for unique human cognition. Glia encompass all cells in the brain that are not neurons. This includes oligodendrocytes, which wrap lipid-rich processes around axons and speed up action potential conduction; astrocytes, star-shaped cells that tile the brain and interact with neurons and synapses via thousands of fine processes; and microglia, the brain's resident immune cells (Allen, 2014) . There is an increase in the glia-to-neuron ratio with increasing brain size, with the human brain estimated to be half glial cells and half neurons (Allen, 2014) . In fact, Einstein was shown to have a higher ratio of glia to neurons than the average person, giving rise to the intriguing notion that glial cells provide more than just support and are actively involved in higher brain function (Diamond et al., 1985) . Astrocytes in particular perform many important roles that impact brain performance. These include maintaining brain homeostasis through potassium buffering, uptake of neurotransmitters, and supplying energy to neurons (Allen, 2014) ; inducing new synapses to form between neurons and eliminating excess synapses; and responding to neurotransmitters with increases in intracellular calcium and signaling back to neurons to regulate neurotransmission. On the flip side, increasing studies have shown that in neurological disorders as diverse as autism spectrum disorder, schizophrenia, and Alzheimer's disease, alterations in glial cell function are contributing to the neuropathology (BlancoSuá rez et al., 2017; Windrem et al., 2017) . Therefore, having realistic models for studying human astrocyte maturation and function is important for understanding both healthy brain function and disease.
The current paper focuses on developing a method to study the maturation of human astrocytes in vitro (Sloan et al., 2017) . The study of human astrocytes has been limited by resource availability, but importantly, intriguing differences between rodent and human astrocytes have been identified in the work that has been done. For example, human astrocytes are larger than rodent astrocytes, a subset of human astrocytes have long processes that span the cerebral cortex, human astrocytes have differential gene expression when compared to rodent astrocytes, and when human astrocytes are transplanted into mouse brains, they enhance the performance of the mice in learning and memory tasks (Chandrasekaran et al., 2016; Han et al., 2013; Krencik et al., 2017) . Currently available techniques to study human astrocytes include anatomical studies of human post-mortem tissue, derivation of iPSC astrocytes in two-dimensional culture that resemble immature human astrocytes, and engraftment of glial progenitors into mice to provide a more complex environment (Chandrasekaran et al., 2016) . What have been lacking are techniques to study the development and function of mature human astrocytes in a native environment. In this issue of Neuron, Sloan and colleagues take steps to address these issues by developing a long-term three-dimensional brain spheroid model that allows for the generation, development, and maturation of human astrocytes while in contact with human neurons (Sloan et al., 2017) . During brain development neurons are generated before astrocytes. By allowing human cerebral cortical spheroids (hCSs) derived from human pluripotent stem cells (Paş ca et al., 2015) to develop and mature in vitro for months to years, Sloan and colleagues were able to track the development of astrocytes in hCSs and characterize their functional properties (Sloan et al., 2017) . Characterization included monitoring gene expression as hCSs and astrocytes matured, and assaying functional properties of astrocytes, such as the ability to take up glutamate and to regulate neuronal synapse number and function at different stages of astrocyte maturation. An elegant aspect of this study is the purification of astrocytes and neurons from the hCS at different stages of development using antibodies that recognize specific cell-surface molecules on the two cell types, a technique known as immunopanning (see Figure 1 in Sloan et al., 2017) . This then allows the culture of purified human astrocytes and neurons from different developmental stages, and for the authors to address questions about what properties of mature astrocytes are intrinsic and which require the continuous presence of neurons.
The authors first asked, how do astrocyte morphology and gene expression change with time in vitro in the hCS, from 100 to 590 days in vitro (DIV) (see Figure 2 in Sloan et al., 2017) ? These features were compared to known developmental and maturational properties of human astrocytes. For example, astrocytes acutely isolated from the hCS by immunopanning showed an increasingly complex morphology with age of the hCS, characteristic of mature astrocytes. Culturing these astrocytes for a week demonstrated that the morphological differences were maintained-the older the age at isolation, the more processes and branching complexity the astrocyte had, suggesting the cells had undergone irreversible maturational changes in the hCS. Next, the gene expression of acutely isolated hCS astrocytes of different stages was compared to existing RNAseq data from human fetal and adult astrocytes, focusing on the top 100 astrocyte-enriched genes in the fetal and adult cells. This analysis demonstrated that as the hCS matured, the astrocyte gene expression moved from overlapping with the fetal astrocytes at 100 DIV to overlapping with adult astrocytes at 500 DIV, with an intermediate gene expression at time points in between. Interestingly, a subset of the top 100 adult astrocyte genes were not upregulated in the hCS with age, suggesting that additional cues not present in this system regulate their expression in astrocytes in vivo in the human brain, which will be interesting to identify in future work.
It is increasingly being appreciated that astrocytes are not one homogeneous cell type, but instead that they are a heterogeneous population of cells. One way to assess astrocyte heterogeneity is using single-cell RNAseq to determine the gene expression of individual astrocytes, the question next addressed (see Figure 3 in Sloan et al., 2017) . Single astrocytes were isolated from hCS at different times in vitro, from 100 to 450 DIV, and RNAseq was performed. Clustering analysis placed the astrocytes into three groups which correlated with their in vitro agemost astrocytes isolated at 100 DIV were in cluster 1, which was enriched for genes involved in cell proliferation. Astrocytes of intermediate age (130-175 DIV) fell into cluster 2, and the oldest astrocytes (450 DIV) were mostly in cluster 3, associated with markers of mature astrocytes. This separation of individual astrocytes into clusters based on time in vitro in the hCS strengthens the bulk RNaseq data in Figure 2 from Sloan et al. (2017) , showing that astrocytes mature the longer they are in the hCS. In the future it will be interesting to determine if further clusters of astrocytes can be extracted from this data that are not related to maturational state and that can give insight into local astrocyte specialization-for example, cortical region-dependent gene expression.
Having extensively validated that morphology and gene expression of astrocytes matures as the hCS matures in vitro, the authors next investigated whether known functions of astrocytes also change with time (see Figure 4 in Sloan et al., 2017) . Both immature (153 DIV) and mature (419 DIV) hCS-derived astrocytes were able to take up glutamate via glutamate transporters, a key in vivo role of astrocytes. Immature astrocytes have been demonstrated to phagocytose synapses in the rodent brain, and this ability is important for removing excess synapses during development. Whether human astrocytes can phagocytose synapses is unknown, and was addressed using an in vitro phagocytosis assay. Astrocytes isolated from immature hCS (100 DIV) robustly phagocytosed rodent synaptosomes, whereas those isolated from mature hCS (590 DIV) displayed little phagocytic activity, showing that, like in mouse, this function of astrocytes is restricted to developmental stages. Another well-known function of developing rodent astrocytes is the ability to induce new synapses to form between neurons via the release of multiple secreted factors. The ability of hCS astrocytes to induce synapses to form between rodent neurons was assayed, and like rodent astrocytes, the hCS astrocytes also induced synapses to form. Surprisingly, the synapse-inducing property of astrocytes did not significantly change with the age of the astrocytes at isolation from the hCS, and was constant for both immature and mature astrocytes. It will be interesting to determine if the synaptogenic ability of astrocytes is due to the same astrocyte-derived signals at each age or if the signals vary between immature and mature cells. It would also be intriguing to carry out these experiments with age-matched human neurons, rather than juvenile rodent neurons, to determine if the ability of the neurons to respond to the synaptogenic cues changes with age. The final characterization was whether astrocytes of different ages differentially affect neuronal function, focusing on neuronal calcium signaling. This was assessed by isolating astrocytes from hCS at different stages (117-437 DIV) and culturing them with young hCS neurons (isolated at 83 DIV). Depolarization of the neurons by application of KCl led to a calcium rise in the neurons, which, interestingly, was larger when the neurons were cultured with mature astrocytes (437 DIV) compared to immature. As with synapse formation, it will be important to determine if these effects are seen in age-matched neurons.
This work develops and characterizes hCS as an in vitro system for enabling human astrocyte maturation and provides a model system to track how human astrocytes develop over time. Future questions include asking how the generation of a more complex environment in the hCS, for example by the inclusion of more cell types, will affect astrocyte maturation and function. This is particularly important, as even though the astrocytes display many markers of maturation with prolonged time in the hCS, there are still significant differences between theses astrocytes and adult human astrocytes. This may be due to a lack of cues, or may be an issue of time-it will be difficult to test the latter without maintaining the hCS for many years to match human development. One way of introducing new cell types to the hCS (which mainly consists of excitatory glutamatergic neurons) would be by adding GABAergic inhibitory neurons using procedures just published by the same group , to determine if astrocytes mature in the same way in the presence of inhibition and altered neuronal network function. Other cell types that interact with astrocytes in the human brain, including microglia, oligodendrocytes, and vascular endothelial cells, may also be sources of signals that alter how astrocytes develop and mature, and studying how each of these alters astrocyte function will give important insight into cell-cell signaling that occurs in the developing human brain. Due to the large number of neurological disorders that have a glial component, an exciting use for the hCS will be in modeling human disease to determine to what extent altered astrocyte function contributes to disease onset and progression, and for testing of potential therapies.
In this issue, Gordon et al. (2017) use dense sampling of resting and task fMRI within individuals to demonstrate that patterns of correlation in resting fMRI are closely aligned with functional architecture as identified using task fMRI.
Our ability to understand the brain is ultimately constrained by the kinds of measurements that we make and how we analyze them. In human neuroimaging, researchers have (with a few notable exceptions) generally collected a relatively small amount of data on each of a few dozen individuals, and then warped their brains together in order to find areas that are commonly active across people in response to some task manipulation, often after spatially smoothing (i.e., blurring) the data to allow for anatomical differences. More recently, resting-state fMRI has been used to examine the patterns of correlated activity across the brain. Both of these approaches have been successful, in the sense that they have identified reliable patterns of activity or connectivity across people. This success implies that there must be a reasonably high degree of functional homology across individuals at this spatial scale; in fact, for many brain networks, this homology is present not just between humans but with other mammalian species as well. At the same time, we know that this homology must break down at some level; the remarkable maps of individual rodent somatosensory representations by Riddle and Purves (1995) showed that even in this highly stereotyped system there were substantial differences across individuals in the fine-grained spatial organization of somatosensory cortex, overlaid on a consistent organization at a coarser level. An essential question for neuroimaging researchers is whether our approach of averaging small amounts of data from larger groups of individuals may have led us to mischaracterize some aspects of the functional organization of the brain.
A new paper by Gordon et al. (2017) in this issue of Neuron, together with a recent paper by Braga and Buckner (2017) in the July 19 issue of Neuron, suggests that the answer to this question is positive and will add fuel to a growing movement toward the deeper characterization of individual brains. The utility of dense sampling first became evident in the work of Laumann et al. (2015) , which characterized in detail the brain of a single individual (the present author) on the basis of 14 hr of resting MRI data collected over the course of 18 months. This work showed idiosyncratic features of network organization that had not been previously seen in group studies; however, the use of a single individual made it unclear how generalizable these features were. To test that question, Gordon et al. started the ''Midnight Scan Club'' (MSC), in which a number of the investigators scanned themselves on 10 subsequent days at midnight, including 30 min of resting fMRI each night as well as several taskbased fMRI scans. A notable feature of the MSC study is that the data were released openly (via the OpenfMRI project) upon publication of the paper,
